Tuesday, May 28, 2024
Homebreast cancerdaclizumab (Zinbryta): MS Drug Side Effects & Interactions

daclizumab (Zinbryta): MS Drug Side Effects & Interactions

What is daclizumab, and how does it work?

  • Daclizumab (Zinbryta) is an injectable medication used for treating multiple sclerosis
    (MS). Its mechanism of action is not completely understood. Available data
    suggests that it may work by modifying immune processes that may be responsible
    for causing MS by interfering with the activation of lymphocytes (a type of
    white blood cell) that cause inflammation and destruction of nerves in patients
    with MS. Daclizumab does not cure MS. It decreases the number of MS flares and
  • The FDA approved daclizumab in May, 2016.

What brand names are available for daclizumab?

  • Zinbryta is the brand name for daclizumab available in the US.

Is daclizumab available as a generic drug?

  • No, this drug is not available as a generic.

Do I need a prescription for daclizumab?

  • Yes, you need a prescription for this drug.

What are the uses for daclizumab?

  • Daclizumab is used for the treatment of adult patients with relapsing
    forms of
    multiple sclerosis (MS).
  • It is reserved for patients who have
    had an inadequate response to two or more
    MS drugs because of its safety

Why is there a black box warning for daclizumab?

  • Daclizumab can cause severe
    liver injury including life-threatening events,
    liver failure, and autoimmune hepatitis. Transaminase and
    bilirubin levels
    should be obtained before starting daclizumab, monthly during treatment, and up
    to 6 months after the last dose.
  • It should not be used in patients with liver problems.
  • This drug can cause immune-mediated disorders including skin reactions,
    lymphadenopathy (enlargement of lymph nodes),
    non-infectious colitis, and other
    immune-mediated disorders. These conditions may require treatment with oral or
    injectable corticosteroids or medication to suppress the immune system.
  • Daclizumab is available only through a restricted distribution program called
    the ZINBRYTA REMS Program.

What are the side effects of daclizumab?

Common side effects include:

Other side effects include:

Other less common side effects include:

Possible serious side effects include:

  • Liver damage
  • Immune mediated disorders (for example, skin reactions, colitis)
  • Serious allergic reactions (anaphylaxis, angioedema)
  • Severe infections
  • Depression
  • Suicidal thoughts,
  • Decreased numbers of white blood cells
  • Severe skin reactions
  • Non-infectious colitis

What is the dosage for daclizumab?

  • The recommended dose is 150 mg injected under the skin once monthly.


What kind of disease is multiple sclerosis?
See Answer

Which drugs or supplements interact with daclizumab?

  • Combining daclizumab with prescription drugs,
    non-prescription drugs, herbal products, or dietary supplements that affect the
    liver may increase the risk of liver damage. Such combinations should be avoided
    when possible or used cautiously.

Is daclizumab safe to use during pregnancy or while breastfeeding?

  • This drug has not been adequately evaluated in
    pregnant women.
  • There is no information about the secretion of  this drug in
    human milk.

Latest Neurology News

Trending on MedicineNet

Are Your MS Drugs

Learn More on

What else should I know about daclizumab?

What preparations of daclizumab are available?
  • Injection: 150 mg/mL solution in a single-dose prefilled
How should I keep daclizumab stored?
  • Daclizumab should be stored in a refrigerator between 2 C to 8 C (36 F to 46
    F) and in the original carton to protect it from light.
  • It should not be frozen
    or exposed to temperatures above 30 C (86 F). It should be discarded if frozen.
  • When refrigeration is unavailable, this drug may be stored for 30 days at 30 C
    (86 F) protected from light. It should not be refrigerated after it is
    warmed to room temperature. It should be discarded after 30 days if it is not

Most Popular